
CAS 489415-96-5
:Fórmula:C31H33N3O5
InChI:InChI=1S/C31H33N3O5/c1-22-20-25(8-9-26(22)39-21-23-6-3-2-4-7-23)29(35)27-28(24-10-12-32-13-11-24)34(31(37)30(27)36)15-5-14-33-16-18-38-19-17-33/h2-4,6-13,20,28,35H,5,14-19,21H2,1H3/b29-27-/t28-/m0/s1
Clave InChI:VVYIXKBHQQSREP-SUUDBTLLSA-N
SMILES:CC1=C(C=CC(=C1)/C(=C/2\[C@@H](N(C(=O)C2=O)CCCN3CCOCC3)C4=CC=NC=C4)/O)OCC5=CC=CC=C5
Filtrar por
Porcentaje de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Se han encontrado 6 productos.
- Precio más bajo
- Precio más alto
- Pureza más baja
- Pureza más alta
- Entrega estimada más rápida
SBC-115076
CAS:SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.Fórmula:C31H33N3O5Pureza:97.07% - 99.89%Forma y color:SolidPeso molecular:527.6108SBC-115076
CAS:4-(4-(Benzyloxy)-3-methylbenzoyl)-3-hydroxy-1-(3-morpholinopropyl)-5-(pyridin-4-yl)-1,5-dihydro-2H-pyrrol-2-oneFórmula:C31H33N3O5Pureza:99%Peso molecular:527.61SBC-115076
CAS:SBC-115076 is a monoclonal antibody that binds to the tumor necrosis factor-α (TNF-α) receptor and blocks TNF-α signaling. This drug has been shown to be effective in treating cardiac disease, malignant brain tumors, and atherosclerotic cardiovascular disease. The SBC-115076 antibody is activated by TNF-α, which is released from cells of the immune system or cancer cells. The SBC-115076 antibody prevents TNF-α from binding to its receptor on the surface of other cells and thus prevents activation of those cells. This drug has also been shown to be effective in inhibiting growth of cultured cells, such as cancer cells.Fórmula:C31H33N3O5Pureza:Min. 95%Peso molecular:527.61 g/mol





